Product
DDP
1 clinical trial
1 indication
Indication
Cervical CancerClinical trial
Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Single-center, Phase II Clinical StudyStatus: Recruiting, Estimated PCD: 2024-12-31